Mackay Shields LLC’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-114,222
Closed -$32.7M 503
2022
Q1
$32.7M Sell
114,222
-4,486
-4% -$1.15M 0.29% 88
2021
Q4
$32.8M Sell
118,708
-2,700
-2% -$684K 0.27% 94
2021
Q3
$28.1M Sell
121,408
-3,957
-3% -$977K 0.26% 101
2021
Q2
$28.8M Sell
125,365
-38,155
-23% -$7.66M 0.27% 96
2021
Q1
$30.5M Sell
163,520
-27,320
-14% -$5.34M 0.22% 90
2020
Q4
$32.2M Sell
190,840
-8,198
-4% -$1.22M 0.22% 85
2020
Q3
$29.5M Buy
199,038
+16,662
+9% +$2.58M 0.2% 98
2020
Q2
$29.9M Sell
182,376
-40,828
-18% -$6.27M 0.24% 89
2020
Q1
$31M Buy
223,204
+71,310
+47% +$9.8M 0.29% 76
2019
Q4
$20M Sell
151,894
-4,118
-3% -$477K 0.14% 182
2019
Q3
$17.4M Sell
156,012
-24,331
-13% -$2.71M 0.11% 224
2019
Q2
$20M Sell
180,343
-90,564
-33% -$10.7M 0.14% 169
2019
Q1
$35.2M Sell
270,907
-21,102
-7% -$2.57M 0.25% 84
2018
Q4
$33.8M Buy
292,009
+48,327
+20% +$5.4M 0.27% 73
2018
Q3
$26.1M Sell
243,682
-250,525
-51% -$25M 0.2% 132
2018
Q2
$42.2M Sell
494,207
-74,942
-13% -$6.16M 0.29% 71
2018
Q1
$44M Buy
+569,149
New +$45.8M 0.27% 69

Other funds holding LLY

Mackay Shields LLC's LLY Position: Q2 2022 in Review

Mackay Shields LLC sold out of Eli Lilly (LLY) in Q2 2022, closing a stake of 114,222 shares — an estimated $32.7M sold.

Mackay Shields LLC first reported a position in LLY in Q1 2018 and held it in 17 quarters. The position peaked at $44M in Q1 2018. 2,445 funds tracked by Wall St. Rank hold LLY as of Q2 2022.

  • Mackay Shields LLC reported no remaining Eli Lilly position as of Q2 2022 after selling out during the quarter.
  • Mackay Shields LLC sold 114,222 Eli Lilly shares in Q2 2022, an estimated $32.7M.
  • Mackay Shields LLC first reported a position in Eli Lilly in Q1 2018 and held it in 17 quarters.
  • Mackay Shields LLC's Eli Lilly position peaked at $44M in Q1 2018.
  • 2,445 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2022.

Based on Mackay Shields LLC's 13F filing for Q2 2022, filed 3 Aug 2022.